AU2003275941A1 - Recombinant protein variants - Google Patents

Recombinant protein variants Download PDF

Info

Publication number
AU2003275941A1
AU2003275941A1 AU2003275941A AU2003275941A AU2003275941A1 AU 2003275941 A1 AU2003275941 A1 AU 2003275941A1 AU 2003275941 A AU2003275941 A AU 2003275941A AU 2003275941 A AU2003275941 A AU 2003275941A AU 2003275941 A1 AU2003275941 A1 AU 2003275941A1
Authority
AU
Australia
Prior art keywords
protein
allergen
protein variant
naturally occurring
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003275941A
Other languages
English (en)
Inventor
Jens Holm
Jorgen Nedergaard Larsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ALK Abello AS
Original Assignee
ALK Abello AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ALK Abello AS filed Critical ALK Abello AS
Publication of AU2003275941A1 publication Critical patent/AU2003275941A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43568—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from wasps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2299/00—Coordinates from 3D structures of peptides, e.g. proteins or enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Insects & Arthropods (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003275941A 2002-11-01 2003-10-31 Recombinant protein variants Abandoned AU2003275941A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US42298302P 2002-11-01 2002-11-01
DKPA200201686 2002-11-01
DKPA200201686 2002-11-01
US60/422,983 2002-11-01
PCT/DK2003/000744 WO2004039834A2 (en) 2002-11-01 2003-10-31 Recombinant protein variants

Publications (1)

Publication Number Publication Date
AU2003275941A1 true AU2003275941A1 (en) 2004-05-25

Family

ID=35719237

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003275941A Abandoned AU2003275941A1 (en) 2002-11-01 2003-10-31 Recombinant protein variants

Country Status (8)

Country Link
US (2) US7384635B2 (https=)
EP (1) EP2270164A3 (https=)
JP (1) JP2006520184A (https=)
CN (1) CN1714153A (https=)
AU (1) AU2003275941A1 (https=)
CA (1) CA2503886A1 (https=)
PL (1) PL375218A1 (https=)
WO (1) WO2004039834A2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002070665A2 (en) * 2001-03-02 2002-09-12 The Rockefeller University Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
AT501101B1 (de) * 2004-12-02 2008-01-15 Biomay Ag Protein-allergen-derivat
ZA200707413B (en) 2005-03-18 2009-01-28 Cytos Biotechnology Ag Cat allergen fusion proteins and uses thereof
HUE029021T2 (en) 2005-06-21 2017-02-28 Xoma (Us) Llc IL-1beta-binding antibodies and fragments thereof
WO2008010837A2 (en) * 2005-12-15 2008-01-24 The Regents Of The University Of California Noncompetitive immunoassays to detect small molecules
EP3124045A3 (en) 2006-12-20 2017-05-03 Xoma (Us) Llc Treatment of il-1 beta related diseases
EP2028188A1 (en) * 2007-08-21 2009-02-25 Biomay AG Hypoallergenic molecules
SI2391650T1 (sl) 2007-12-20 2015-03-31 Xoma (Us) Llc Postopki za zdravljenje protina
ITMI20111489A1 (it) * 2011-08-03 2013-02-04 Lofarma Spa Varianti ipoallergeniche dell'allergene maggiore mal d 1 di malus domestica
WO2013096516A1 (en) 2011-12-19 2013-06-27 Xoma Technology Ltd. Methods for treating acne
RU2597782C1 (ru) * 2015-08-25 2016-09-20 Василий Николаевич Яковлев Способ определения содержания продуктов протеолиза в плазме крови и диагностическая тест-система для его осуществления
WO2021097174A1 (en) * 2019-11-13 2021-05-20 The Regents Of The University Of Michigan Nanoemulsion compositions for treating aeroallergen associated allergy and inflammation
WO2021178572A1 (en) * 2020-03-03 2021-09-10 The Regents Of The University Of California Non-invasive detection of salivary autoantibodies

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT401180B (de) * 1990-08-13 1996-07-25 Biomay Biotech Prod Für das baumpollenallergen p14 codierende rekombinante dna-moleküle, daraus hergestellte und abgeleitete polypeptide und deren verwendung
JP3316535B2 (ja) * 1995-03-28 2002-08-19 アサヒビール株式会社 ダニアレルゲンの改変体およびその製造法
DE19810906A1 (de) 1998-03-13 1999-09-16 Basf Ag Reaktivfarbstoffe mit einem Kombinationsanker
PL194804B1 (pl) * 1998-03-16 2007-07-31 Alk Abello As Zrekombinowany alergen, sposób przygotowywania zrekombinowanego alergenu, kompozycja farmaceutyczna oraz zastosowanie zrekombinowanego alergenu do przygotowywania leku do wywoływania odpowiedzi immunologicznej u osobnika i do przygotowywania leku do leczenia, zapobiegania lub osłabiania reakcji alergicznych
ATE414773T1 (de) 2000-11-16 2008-12-15 Alk Abello As Mutante allergene
WO2002070665A2 (en) * 2001-03-02 2002-09-12 The Rockefeller University Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
US7290199B2 (en) * 2004-11-19 2007-10-30 International Business Machines Corporation Method and system for improved buffer utilization for disk array parity updates

Also Published As

Publication number Publication date
US20090054625A1 (en) 2009-02-26
US7384635B2 (en) 2008-06-10
EP2270164A3 (en) 2011-05-04
JP2006520184A (ja) 2006-09-07
CA2503886A1 (en) 2004-05-13
CN1714153A (zh) 2005-12-28
US20040171116A1 (en) 2004-09-02
EP2270164A2 (en) 2011-01-05
WO2004039834A2 (en) 2004-05-13
PL375218A1 (en) 2005-11-28
WO2004039834A3 (en) 2004-08-26

Similar Documents

Publication Publication Date Title
US20090054625A1 (en) Recombinant protein variants
Tscheppe et al. Recombinant allergens in structural biology, diagnosis, and immunotherapy
KR100919914B1 (ko) 신규한 돌연변이체 알레르겐
US20020052490A1 (en) Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments
CN102131523A (zh) 供乳变态反应的免疫疗法用的经修饰的beta乳球蛋白
PL196830B1 (pl) Modyfikowane alergeny rekombinacyjne pyłku Graminae, sposób ich otrzymywania, zawierające je preparaty farmaceutyczne i sposób ich otrzymywania oraz ich zastosowanie do immunospecyficznej terapii alergii i wytwarzania leków do immunospecyficznej terapii alergii
JP4253122B2 (ja) アレルゲンの非アナフィラキシー形およびその使用
JP4446887B2 (ja) オオアワガエリ花粉アレルゲンＰｈｌＰ７に基づく低アレルゲン性アレルギーワクチン
CA2649057A1 (en) Phl p 1 allergen derivative
RU2327739C2 (ru) ПОСЛЕДОВАТЕЛЬНОСТЬ ДНК И ПОЛУЧЕНИЕ АЛЛЕРГЕНА ПЫЛЬЦЫ ТРАВ Phl p 4 С ПОМОЩЬЮ РЕКОМБИНАНТНЫХ СПОСОБОВ
EP1558740A2 (en) Recombinant protein variants
HK1152729A (en) Recombinant protein variants
US20180002387A1 (en) Variants of group 5 allergens of the true grasses having reduced allergeneity due to mutagenesis of proline residues
JP7505788B2 (ja) Ｃ９ｏｒｆ７２に由来するジペプチドリピートタンパク質に対して指向化されたペプチド免疫原コンストラクト
CN102811735B (zh) 由于脯氨酸残基突变而具有降低的致敏性的禾本科的第6组过敏原的变异体
EP1369483A1 (en) Allergen from mugwort pollen
WO2024178329A2 (en) Mutant ara h 2 and ara h 6 proteins and uses thereof
WO2024174031A1 (en) Conserved epitopes in coronaviruses and vaccines and antibodies thereto
CA2523402A1 (en) Group 1 mite polypeptide variants
ES2384231T3 (es) Proteínas híbridas de pincipales alérgenos de Parietaria judaica y usos de las mismas
AU2012205288B2 (en) DNA-sequence and recombinant production of group 4 major allergens from cereals
Ruffilli et al. Characterization of a Dominant Epitope of the Major Allergens of Parietaria

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application